The Role of The Gut Microbiome in Parkinson's Disease

被引:9
作者
Gallop, Amy [1 ]
Weagley, James [2 ]
Paracha, Saif-ur-Rahman [1 ]
Grossberg, George [3 ]
机构
[1] St Louis Univ, Dept Psychiat & Behav Neurosci, St Louis, MO 63104 USA
[2] Washington Univ, Div Biol Sci, St Louis, MO 63110 USA
[3] St Louis Univ, Dept Psychiat & Behav Neurosci, Geriatr Psychiat, St Louis, MO 63104 USA
关键词
Parkinson's disease; microbiome; inflammation; neuro-degeneration; gut-brain axis; HELICOBACTER-PYLORI INFECTION; INTESTINAL BACTERIAL OVERGROWTH; CHAIN FATTY-ACIDS; TRYPTOPHAN-METABOLISM; COFFEE CONSUMPTION; KYNURENINE PATHWAY; DAIRY-PRODUCTS; LIPOPOLYSACCHARIDE; DYSBIOSIS; MODEL;
D O I
10.1177/08919887211018268
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The gut microbiota is known to play a role in various disease states through inflammatory, immune and endocrinologic response. Parkinson's Disease is of particular interest as gastrointestinal involvement is one of the earlier features seen in this disease. This paper examines the relationship between gut microbiota and Parkinson's Disease, which has a growing body of literature. Inflammation caused by gut dysbiosis is thought to increase a-synuclein aggregation and worsen motor and neurologic symptoms of Parkinson's disease. We discuss potential treatment and supplementation to modify the microbiota. Some of these treatments require further research before recommendations can be made, such as cord blood transplant, antibiotic use, immunomodulation and fecal microbiota transplant. Other interventions, such as increasing dietary fiber, polyphenol and fermented food intake, can be made with few risks and may have some benefit for symptom relief and speed of disease progression.
引用
收藏
页码:253 / 262
页数:10
相关论文
共 106 条
  • [1] Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice
    Abbasi, Mohammad Hossein
    Esmaeili, Sara
    Habibi, Seyed Amirhassan
    Shahidi, Gholam Ali
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 79 : 219 - 223
  • [2] Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
    Agus, Allison
    Planchais, Julien
    Sokol, Harry
    [J]. CELL HOST & MICROBE, 2018, 23 (06) : 716 - 724
  • [3] The association between Mediterranean diet adherence and Parkinson's disease
    Alcalay, Roy N.
    Gu, Yian
    Mejia-Santana, Helen
    Cote, Lucien
    Marder, Karen S.
    Scarmeas, Nikolaos
    [J]. MOVEMENT DISORDERS, 2012, 27 (06) : 771 - 774
  • [4] Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
    AlDakheel, Amaal
    Kalia, Lorraine V.
    Lang, Anthony E.
    [J]. NEUROTHERAPEUTICS, 2014, 11 (01) : 6 - 23
  • [5] Alifirova V M, 2016, Vestn Ross Akad Med Nauk, V71, P427, DOI 10.15690/vramn734
  • [6] Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy
    Altschuler, E
    [J]. MEDICAL HYPOTHESES, 1996, 47 (05) : 413 - 414
  • [7] Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism
    Andrews, Zane B.
    Erion, Derek
    Beiler, Rudolph
    Liu, Zhong-Wu
    Abizaid, Alfonso
    Zigman, Jeffrey
    Elsworth, John D.
    Savitt, Joseph M.
    DiMarchi, Richard
    Tschoep, Matthias
    Roth, Robert H.
    Gao, Xiao-Bing
    Horvath, Tamas L.
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (45) : 14057 - 14065
  • [8] The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols
    Aryal, Sunisha
    Skinner, Taylor
    Bridges, Bronwyn
    Weber, John T.
    [J]. MOLECULES, 2020, 25 (19):
  • [9] Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
    Barichella, Michela
    Severgnini, Marco
    Cilia, Roberto
    Cassani, Erica
    Bolliri, Carlotta
    Caronni, Serena
    Ferri, Valentina
    Cancello, Raffaella
    Ceccarani, Camilla
    Faierman, Samanta
    Pinelli, Giovanna
    De Bellis, Gianluca
    Zecca, Luigi
    Cereda, Emanuele
    Consolandi, Clarissa
    Pezzoli, Gianni
    [J]. MOVEMENT DISORDERS, 2019, 34 (03) : 396 - 405
  • [10] Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients
    Bedarf, J. R.
    Hildebrand, F.
    Coelho, L. P.
    Sunagawa, S.
    Bahram, M.
    Goeser, F.
    Bork, P.
    Wuellner, U.
    [J]. GENOME MEDICINE, 2017, 9